心房颤动侦测AFIB专利技術

心房颤动侦测专利技术

迈克大夫的 AFIB 专利技术可以在血压测量过程中侦测心房颤动,做为提早就医咨询的方法。

pad and watchbp pad

拥有多国专利

TW 专利号 :第I 328442号
CN 专利号 :ZL. 2006 8 0005943.7
EU 专利号 :EP1858407B1
US 专利号 :US7680532B2 / US7706868B2
JP 专利号 :JP5452870B2
AFIB-what

心房顫動(AFIB)是什么?

心房颤动是最致命的一种心律不齐,中风风险高出五倍!

迈克大夫的 AFIB 侦测专利技术能有效筛检出最危险致命的心律不整 - 心房颤动,排除其他因生理与人为因素造成的心律不整。经由迈克大夫的专利技术可以在血压测量过程中自动侦测心房颤动,使用者在 MAM 三次平均模式下进行测量,如发现心房颤动,屏幕会显示图标做为及早就医确诊与医疗咨询的方法,帮助病患了解自身健康状况。

准确专注筛检心房颤动

临床证实 Microlife 的心房颤动侦测具有高度敏感性(98%)与高度特异性(92%)

灵敏度 98%

临床研究累计超过 10000 名样本,
并发表于国际知名期刊。

特異性 92%

经临床实证,在基层医疗/居家量测血压,
同时侦测心房颤动,可作为 AF 初筛的可靠工具。

rocommend

获英国国家健康与照顾卓越研究院 NICE 官方正式推荐 :

  • 医师专业推荐 :No.1 的心房颤动侦测技术!
  • Microlife 的心房颤动侦测技术,已经临床实验证明了准确度,研究也显示在第一线临床使用,有助于筛检出新的 AFIB 个案。
  • 建议使用于可能罹患高血压的高危险群&高血压族群的血压管理。

国际临床实证列表

  Patients (n) Setting Average
age (y)
AF
n (%)
Non-AF
n (%)
Sinus (n) Sensitivity
(%)
Specificity
(%)
Wiesel 2004 450 Hospital 69 53(12) 1 396 100 92
Stergiou 2009 73 Hospital 71 27(37) 23 23 100 89
Wiesel 2004 405 Hospital 73 93(23) 64 248 97 89
Wiesel 2004 405 Hospital 73 93(23) 64 248 97 89
Wiesel 2004 405 Hospital 73 93(23) 64 248 97 89
Wiesel 2004 405 Hospital 73 93(23) 64 248 97 89
Wiesel 2004 405 Hospital 73 93(23) 64 248 97 89

2013 Oxford Trail 牛津临床试验

著名的英国牛津大学在2013年,针对1,000名家医科患者进行了一项随机临床试验 ,研究结果表明:

Microlife 的 AFIB 对于心房颤动的初步筛检来说是最好的选择,量血压同时量测,操作简单不需专业解释。 且准确度可媲美诊间使用的单导 ECG。

所以在基层医疗与居家使用上,Microlife AFIB 比 ECG 更适合做为房颤的筛检工具。

这些资料建议使用心房颤动技术进行居家血压量测,有优异的诊断准确度,因此于初期诊断时可用来作为可靠的筛检试验。– Dr. George S. Stergiou

国际临床实证列表

Nichols M TN, Luengo-Fernandez R, Leal J, Gray A, Scarborough P, Rayner M European Cardiovascular Disease Statistics 2012. European Heart Network, Brussels, European Society of Cardiology, Sophia Antipolis 2012.

Boriani G, Laroche C, Diemberger I, Fantecchi E, Popescu MI, Rasmussen LH et al.: Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry. Am J Med 2015; 128:509-518 e502.

Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S: Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol 2014; 6:213-220.

Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA et al.: Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 2014; 370:2478-2486.

Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J et al.: Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med 2014; 370:2467-2477.

Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al.: 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. Europace 2012; 14:1385-1413.

Hart RG, Benavente O, McBride R, Pearce LA: Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999; 131:492-501.

Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD et al.: Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 2014; 383:955-962.

Verberk WJ, Omboni S, Kollias A, Stergiou GS: Screening for atrial fibrillation with automated blood pressure measurement: Research evidence and practice recommendations. Int J Cardiol 2016; 203:465-473.

Wiesel J, Fitzig L, Herschman Y, Messineo FC: Detection of atrial fibrillation using a modified microlife blood pressure monitor. Am J Hypertens 2009; 22:848-852.

Stergiou GS, Karpettas N, Protogerou A, Nasothimiou EG, Kyriakidis M: Diagnostic accuracy of a home blood pressure monitor to detect atrial fibrillation. J Hum Hypertens 2009; 23:654-658.

Wiesel J, Fitzig L, Herschman Y, Messineo FC: Detection of atrial fibrillation using a modified microlife blood pressure monitor. Am J Hypertens 2009; 22:848-852.

Wiesel J, Abraham S, Messineo FC: Screening for asymptomatic atrial fibrillation while monitoring the blood pressure at home: trial of regular versus irregular pulse for prevention of stroke (TRIPPS 2.0). Am J Cardiol 2013; 111:1598-1601.

Kearley K, Selwood M, Van den Bruel A, Thompson M, Mant D, Hobbs FR et al.: Triage tests for identifying atrial fibrillation in primary care: a diagnostic accuracy study comparing single-lead ECG and modified BP monitors. BMJ Open 2014; 4:e004565.

Wiesel J, Arbesfeld B, Schechter D: Comparison of the Microlife blood pressure monitor with the Omron blood pressure monitor for detecting atrial fibrillation. Am J Cardiol 2014; 114:1046-1048.

Gandolfo C, Balestrino M, Bruno C, Finocchi C, Reale N: Validation of a simple method for atrial fibrillation screening in patients with stroke. Neurol Sci 2015; 36:1675-1678.

Chan PH, Wong CK, Pun L, Wong YF, Wong MM, Chu DW et al.: Head-to-Head Comparison of the AliveCor Heart Monitor and Microlife WatchBP Office AFIB for Atrial Fibrillation Screening in a Primary Care Setting. Circulation 2017; 135:110-112.

Chan PH, Wong CK, Pun L, Wong YF, Wong MM, Chu DW et al.: Diagnostic performance of an automatic blood pressure measurement device, Microlife WatchBP Home A, for atrial fibrillation screening in a real-world primary care setting. BMJ Open 2017; 7:e013685.

Alpert BS, Quinn D, Gallick D: Oscillometric blood pressure: a review for clinicians. J Am Soc Hypertens 2014; 8:930-938.

NICE: WatchBP Home A for opportunistically detecting atrial fibrillation during diagnosis and monitoring of hypertension http://guidance.nice.org.uk/MTG13. 2013; Assessed 18 Aug. 2015.

心房颤动侦测AFIB专利技術 技術相关产品

BP
BP
荣获国际红点设计大奖
BP
BP
心房颤动侦测功能
BP
BP
AFIB心房颤动